MNPR
Monopar Therapeutics
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Fund move
Fund move
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
No thesis.
Linked news
News| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Jupiter TopcoJupiter Topco | $121.7M | 21.12% | — | |
| 2 | RA Capital ManagementRA Capital Management | $61.8M | 10.72% | 0.00% | |
| 3 | BlackRockBlackRockindex-like | $32.3M | 5.60% | +10.19% | |
| 4 | Deerfield ManagementDeerfield | $30.0M | 5.20% | 0.00% | |
| 5 | Saturn V Capital ManagementSaturn V | $28.9M | 5.01% | −9.74% | |
| 6 | SirenSiren | $25.0M | 4.34% | 0.00% | |
| 7 | ADAR1 Capital ManagementADAR1 | $20.1M | 3.50% | −17.66% | |
| 8 | Polar Capital HoldingsPolar Capital | $19.9M | 3.45% | −5.32% | |
| 9 | Vanguard Capital ManagementVanguardindex-like | $19.4M | 3.37% | −4.01% | |
| 10 | Adage Capital Partners GPAdage Capital Partners GP | $19.4M | 3.36% | −32.34% | |
| 11 | TCG Crossover ManagementTCG Crossover | $18.8M | 3.27% | +53.92% | |
| 12 | Wellington Management GroupWellington | $14.7M | 2.55% | −9.12% | |
| 13 | Orbimed AdvisorsOrbimed | $14.6M | 2.53% | new | |
| 14 | Candriam Luxembourg S.C.A.Candriam Luxembourg S.C.A. | $13.3M | 2.30% | new | |
| 15 | Balyasny Asset ManagementBalyasny | $12.5M | 2.16% | −1.39% | |
| 16 | Geode Capital ManagementGeodeindex-like | $10.4M | 1.81% | +12.67% | |
| 17 | Alyeska Investment GroupAlyeska Investment | $9.3M | 1.61% | 0.00% | |
| 18 | State StreetState Streetindex-like | $8.6M | 1.49% | +4.75% | |
| 19 | Vivo CapitalVivo Capital | $8.4M | 1.45% | 0.00% | |
| 20 | Driehaus Capital ManagementDriehaus | $7.8M | 1.35% | +153.47% | |
| 21 | Bank of New York MellonBank of New York Mellonindex-like | $7.1M | 1.24% | −2.13% | |
| 22 | Vestal Point CapitalVestal Point Capital | $7.0M | 1.22% | +15.76% | |
| 23 | Longaeva PartnersLongaeva Partners | $5.2M | 0.90% | new | |
| 24 | Neuberger Berman GroupNeuberger Berman | $5.1M | 0.89% | +30.07% | |
| 25 | Millennium ManagementMillennium | $4.7M | 0.81% | −4.99% |
95 managers report $576.3M of Monopar Therapeutics on form 13F for the quarter ended Jun 30 '26. 16 of them hold 80% of it; Jupiter Topco is largest at 21.12%.
Monopar Therapeutics
69.99
−1.92 · −2.66%
post 69.99 0.00%
No implied move.
No implied move.
Expected move
No implied move.